Immune Response(Search results - 9)
CoronavirusJul 2, 2021, 3:08 PM IST
Johnson & Johnson’s single-shot COVID-19 vaccine shows strong activity against Delta variant
Data showed that the durability of the immune response lasted through at least eight months, the US-based healthcare company said, adding that its vaccine was 85% effective and could also help prevent hospitalization and death.
Top StoriesJun 7, 2021, 12:01 PM IST
Covishield produces more antibodies than Covaxin, shows better antibody response: Study
Two doses of Covishield vaccine produced more antibodies than Covaxin doses, but there were relatively fewer instances of ‘breakthrough infections’ after the latter, reports a study of healthcare workers (HCW) in India.
World NewsDec 22, 2020, 4:39 PM IST
Coronavirus: Can make mutation-beating vaccine in 6 weeks, says BioNTech
"Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," said Ugur Sahin.
United StatesDec 21, 2020, 10:22 AM IST
Coronavirus: Joe Biden to be vaccinated, Trump on sidelines
“We know that infection doesn’t induce a very strong immune response and it wanes over time. So I think, as a clear precaution, it is appropriate to be vaccinated because it’s safe,” Moncef Slaoui, the chief adviser of Operation Warp Speed said.
Coronavirus WorldNov 22, 2020, 8:30 AM IST
US approves emergency use of Regeneron's antibody cocktail for Covid-19 therapy
Clinical evidence from Regeneron's outpatient trials have suggested that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis and in patients who have not yet mounted their own immune response or who have high viral load.
IndiaNov 5, 2020, 6:08 PM IST
India's first indigenous coronavirus vaccine by February 2021?
Bharat Biotech, which recently received approval to conduct Phase III human trials of Covaxin, has said that the vaccine has been found to be safe without any major adverse events in the first two stages of trials and that its goal is to attain strong immune response rate in clinical trials.
WORLDAug 27, 2020, 10:09 AM IST
Coronavirus: Moderna vaccine shows promising results in trials of older adults
Moderna’s potential coronavirus vaccine generated a promising immune response in elderly patients in an early stage clinical trial, the biotech firm announced Wednesday.
WORLDAug 5, 2020, 9:04 AM IST
Coronavirus: Novavax experimental COVID-19 vaccine induces immune response in early study
Novavax research chief Gregory Glenn said the late-stage clinical trial of the experimental COVID-19 vaccine could potentially glean enough data to obtain regulatory approvals as early as December.
WORLDJul 21, 2020, 9:05 AM IST
Coronavirus: UK vaccine trials shows promising early results, raises hopes for COVID-19 vaccine
A test involving more than 1,000 volunteers has shown the vaccine produces a strong immune response and few side effects